MIMP
Grupo de Imaxe Molecular e Física Médica
Publikationen (155) Publikationen, an denen Forscher/innen teilgenommen haben
2024
-
Biodistribution and pharmacokinetics of [89Zr]-anti-VEGF mAbs using PET in glioblastoma rat models
International Journal of Pharmaceutics, Vol. 652
-
Correction to: EANM perspectives for CZT SPECT in brain applications (European Journal of Nuclear Medicine and Molecular Imaging, (2024), 10.1007/s00259-024-06788-6)
European Journal of Nuclear Medicine and Molecular Imaging
-
EANM perspectives for CZT SPECT in brain applications
European Journal of Nuclear Medicine and Molecular Imaging
-
Metrology for advanced radiotherapy using particle beams with ultra-high dose rates
Physics in Medicine and Biology, Vol. 69, Núm. 14
-
Neuroimaging biomarkers in the biological definition of Parkinson’s disease and dementia with Lewy bodies – EANM position on current state, unmet needs and future perspectives
European Journal of Nuclear Medicine and Molecular Imaging
-
Partial volume correction in longitudinal tau PET studies: is it really needed?
NeuroImage, Vol. 289
-
Perspectives of the European Association of Nuclear Medicine on the role of artificial intelligence (AI) in molecular brain imaging
European Journal of Nuclear Medicine and Molecular Imaging
-
Preclinical characterization of endotoxin-induced uveitis models using OCT, PET/CT and proteomics
International Journal of Pharmaceutics, Vol. 662
2023
-
A murine model of BSCL2-associated Celia's encephalopathy
Neurobiology of Disease, Vol. 187
-
Association of periodontitis with cognitive decline and its progression: Contribution of blood-based biomarkers of Alzheimer's disease to this relationship
Journal of Clinical Periodontology, Vol. 50, Núm. 11, pp. 1444-1454
-
Description of a different quantification method for amyloid burden (burdenDPD) and validation of SPECT/CT in cardiac amyloidosis
Revista Espanola de Medicina Nuclear e Imagen Molecular, Vol. 42, Núm. 3, pp. 171-177
-
EANM position paper: theranostics in brain tumours—the present and the future
European Journal of Nuclear Medicine and Molecular Imaging
-
FDA approval of lecanemab: the real start of widespread amyloid PET use? — the EANM Neuroimaging Committee perspective
European Journal of Nuclear Medicine and Molecular Imaging
-
First experimental measurements of 2D microdosimetry maps in proton therapy
Medical Physics, Vol. 50, Núm. 1, pp. 570-581
-
Increased Medial Temporal Tau Positron Emission Tomography Uptake in the Absence of Amyloid-β Positivity
JAMA neurology
-
Pharmacokinetic Evaluation of New Drugs Using a Multi-Labelling Approach and PET Imaging: Application to a Drug Candidate with Potential Application in Neuromuscular Disorders
Biomedicines, Vol. 11, Núm. 2
-
Prevalencia de dislipemia aterogénica, factores relacionados y grado de control lipídico en la población general de Galicia: Estudio GALIPEMIAS
Clínica e investigación en arteriosclerosis, Vol. 35, Núm. 4, pp. 178-184
-
Quantitative PET tracking of intra-articularly administered 89Zr-peptide-decorated nanoemulsions
Journal of Controlled Release, Vol. 356, pp. 702-713
-
Role of systemic inflammatory factors in gastroenteropancreatic neuroendocrine tumors (GEP-NETs) treated with peptide receptor radionuclide therapy (PRRT): From biology to theragnosis
Revista Espanola de Medicina Nuclear e Imagen Molecular, Vol. 42, Núm. 3, pp. 156-162
2022
-
18F-florbetapir PET as a marker of myelin integrity across the Alzheimer’s disease spectrum
European Journal of Nuclear Medicine and Molecular Imaging, Vol. 49, Núm. 4, pp. 1242-1253